Be Wary of the Techno-Fix
By Marcy Darnovsky,
Boston Review
| 11. 19. 2018
In Merve Emre’s essay "All Reproduction is Assisted," her commitment to the emancipatory power of reproductive technologies is untroubled by her own accounts of unsatisfactory endings. Perhaps she assumes that one day soon, when the technologies improve, they will set us free.
In her essay, Merve Emre declares that “all reproduction . . . is assisted.” Few feminists of any wave or stripe would disagree. But if the statement that none of us go it alone is solid, some of Emre’s other moves put her on shaky ground. In her opening volleys, she skips lightly across fifty years of feminist thinking about reproductive technologies, leaping from Shulamith Firestone to Adrienne Rich to xenofeminism, with a brief stop at Donna Haraway’s “A Cyborg Manifesto” (1984). She arrives at a diagnosis of contemporary reproductive culture: it is infected, she says, by “the discourse of the natural.” She takes contemporary feminism to task for this state of affairs, suggesting that it has not been sufficiently enthusiastic about high-tech reproduction and asserting that it “has not done a good enough job articulating what alternate strategies of reproduction may be.”
Is that really a fair critique of feminism today? Most feminists have long been aware that simplistic appeals to nature can justify anything, including gender inequalities and oppression. And while questions about “nature” and “technology” are very...
Related Articles
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes...
By Jim Thomas, Scan the Horizon | 11.19.2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. ...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...
By Ruth Retassie, PET | 10.21.2024